United States · FDA National Drug Code directory
LORATADINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72888-029_47a189dc-792d-a279-e063-6394a90a9adf
- Product NDC
- 72888-029
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- LORATADINE
- Labeler
- Advagen Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200910
- Source listing expiry
- 20271231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (72888-029-09) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 72888-029-09
- 3 BLISTER PACK in 1 CARTON (72888-029-11) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 72888-029-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →